Welcome to the Indiana Chapter Light The Night Walk page!

Thank You Participants, Sponsors, Teams and Volunteers!

This year's Indiana Light The Night Walks were a HUGE success! Thank you to all of our individuals, sponsors, teams and volunteers that help make 2008 great. Together, we have raised more than $850,000 in Indiana, and over $34 million dollars campaign wide to help find a cure for blood cancers. Want to find out how your local Walk did? Click here to find out more!

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Celebrating a Decade of Difference!

In the ten years since The Leukemia & Lymphoma Society’s (LLS) Light The Night® Walk began, the program has grown to include participants in more than 240 communities across the U.S. and Canada. Funds raised by these Walkers since program inception total nearly $120 million.  These funds have made a major impact on the lives of cancer patients and their families. They have helped fuel the growth of LLS-funded research and services that help patients live better, longer lives. 

Over the Past Decade:      

• Nearly half a million patients, family members and healthcare professionals have called the LLS Information Resource Center and received critical information about blood cancers, therapy options and issues surrounding treatment and survival.
  
• Nearly $40 million was disbursed to patients through the LLS Patient Assistance program, for transportation, lodging and other expenses, to help them get the treatment they needed to fight their cancer. 
  
• Over 100,000 patients and family members found comfort and hope through LLS  First Connection and Family Support Groups.
  
• LLS granted $425 million to more than 400 scientists searching for cures and improved treatments for patients.
  
• LLS funding contributed to the development of new drugs that are affecting patient survival and quality of life. Examples include:

              o Velcade® for the treatment of multiple myeloma and mantle cell
                  lymphoma
              o Dracogen® for myelodysplastic syndrome
              o Rituxan® for follicular lymphoma and diffuse large B-cell non-Hodgkin  
                  lymphoma
              o Gleevec® for chronic myelogenous leukemia

• LLS-funded researchers began working in novel research areas that hold 
   great promise for finding cures and better treatments including new, less toxic
   stem cell transplants, immunotherapies and other targeted therapies.
  
• Our Advocacy Network has successfully supported pro-patient legislation including:

              o Doubling NIH funding over a five-year period to advance blood cancer
                 research
              o Extending  Medicare coverage to include oral anti-cancer drugs such as  
                Gleevec®  and thalidomide.
              o Funding to reach underserved blood cancer patients at the Centers for
                 Disease Control and Prevention (CDC).